about
Plasma levels of soluble receptor for advanced glycation end products and coronary atherosclerosis: possible correlation with clinical presentation.Possible role of -374T/A polymorphism of RAGE gene in longevity.Coronary artery disease and depression: possible role of brain-derived neurotrophic factor and serotonin transporter gene polymorphisms.Galectin-3 plasma levels and coronary artery disease: a new possible biomarker of acute coronary syndrome.Association between two polymorphisms in the HLA-G gene and angiographic coronary artery disease.Cardiovascular characteristics of chronic fatigue syndrome.Soluble RAGE plasma levels in patients with coronary artery disease and peripheral artery disease.Excess of activating killer cell immunoglobulin‑like receptors and lack of HLA-Bw4 ligands: A two‑edged weapon in chronic fatigue syndromesRAGE and early signs of cardiac target organ damage in mild hypertensivesAPJ polymorphisms in coronary artery disease patients with and without hypertensionAge of onset of myocardial infarction: is promoter polymorphism of the RAGE gene implicated?Molecular study of receptor for advanced glycation endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue syndromeRelationship between sRAGE and eotaxin-3 with CRP in hypertensive patients at high cardiovascular riskTime-domain heart rate variability in coronary artery disease patients affected by thyroid dysfunctionHyaluronic Acid-Decorated Liposomes as Innovative Targeted Delivery System for Lung Fibrotic CellsFunctional polymorphisms of the receptor for the advanced glycation end product promoter gene in inflammatory bowel disease: a case-control study
P50
Q37176678-DC7BA0C6-59D6-4EAE-93B7-5F8F2FD90F3CQ37375603-439DBDF9-A39A-46A0-BFD5-E2E89D986765Q43249776-95617EA7-0822-481D-8F8C-ADEA7B48583FQ43493519-DBD9C2B9-2F6A-4A28-93FE-81557228E33BQ46983129-D77508CE-5222-4B7E-BD8D-145F36DB6CA3Q49165422-3BC1974B-82BE-4519-99E7-72F461B7EA55Q54605224-49C8EC92-3338-4D27-A65A-BD9A1599F0ADQ61044826-5E5AC81E-1B60-4CBB-B24C-447E8A97C8DBQ64237521-9EDB473D-5983-4ABC-9D41-3CCD985F8416Q82640925-96D4249A-284F-4234-9080-3C57B43BC8C3Q83132893-BF85E48B-7A3A-43C5-9CD0-25CD421914E5Q84703553-220FC12C-2266-4D13-8EE2-83C240149B75Q85420513-E6AF8B31-8A0B-4968-896D-31765AB353A7Q87165361-BD34DD46-5D79-4CDA-AB29-EFD6111D35BAQ90061912-BDC7C9B6-E23B-45D9-ADBA-784BBC37FDD8Q92597636-7E90E428-B767-4CF7-AB8E-D0C9FA36FC56
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Sara Bozzini
@en
Sara Bozzini
@nl
type
label
Sara Bozzini
@en
Sara Bozzini
@nl
prefLabel
Sara Bozzini
@en
Sara Bozzini
@nl
P31
P496
0000-0003-2819-732X